Evidence map›Paper›PMID 23562679›Full record

ArticleExperimental eye research2013

Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).

Vera L Bonilha, Karen G Shadrach, Mary E Rayborn, Yong Li, Gayle J T Pauer, Stephanie A Hagstrom, Sanjoy K Bhattacharya, Joe G Hollyfield

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Histopathological assessments reveal retinal vascular changes, inflammation, and gliosis in patients with lethal COVID-19.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Article
  7. Compartmentalized citrullination in Muller glial endfeet during retinal degeneration.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Perspective on AMD Pathobiology: A Bioenergetic Crisis in the RPE.Investigative ophthalmology & visual science · 2018
    Review
  14. Article
  15. Expression of peptidylarginine deiminase 4 in an alkali injury model of retinal gliosis.Biochemical and biophysical research communications · 2017
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vera L BonilhaDepartment of Ophthalmology, The Cole Eye Institute(i31), Cleveland Clinic Lerner College of Medicine, 9500 Euclid Avenue, Cleveland, OH 44195, USA. bonilhav@ccf.org
Karen G Shadrach
Mary E Rayborn
Yong Li
Gayle J T Pauer
Stephanie A Hagstrom
Sanjoy K Bhattacharya
Joe G Hollyfield
Cleveland Clinic Lerner College of Medicine · USCase Western Reserve University · USUniversity of Miami · US

Funding

Initiating Events in AMD: An Animal Model for the Human DiseaseR01EY014240 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI HOLLYFIELD, JOE GILBERT · 2002 to 2015
$4.9M
TRABECULAR MESHWORK PROTEINS IN GLAUCOMAR01EY016112 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BHATTACHARYA, SANJOY K · 2006 to 2016
$3.7M
Initiating Events in AMD: An Animal Model for the Human DiseaseR56EY014240 · NEI · CLEVELAND CLINIC LERNER COM-CWRU · PI HOLLYFIELD, JOE GILBERT · 2007 to 2007
$386k
NEI NIH HHS EY014240NEI NIH HHS R01 EY014240NEI NIH HHS R01 EY016112NEI NIH HHS R56 EY014240
6 · The paper itself

Abstract

Deimination is a form of protein posttranslational modification carried out by the peptidyl arginine deiminases (PADs) enzymes. PAD2 is the principal deiminase expressed in the retina. Elevated levels of PAD2 and protein deimination are present in a number of human neurological diseases, with or without ocular manifestation. To define the association of deimination with the pathogenesis of age-related macular degeneration (AMD), we studied protein deimination and PAD2 levels in retinas of AMD donor eyes compared to age-matched non-AMD retinas. Eyes from non-AMD and AMD donors were fixed in 4% paraformaldehyde and 0.5% glutaraldehyde in phosphate buffer. Retina and retinal pigment epithelium (RPE) from donor eyes were processed for immunohistochemical detection and western blotting using antibodies to PAD2 and citrulline residues. The ganglion cell, inner plexiform, inner nuclear and outer nuclear layers were labeled by both PAD2 and citrulline antibodies. Changes in the localization of deiminated residues and PAD2 were evident as the retinal layers were remodeled coincident with photoreceptor degeneration in AMD retinas. Immunodetection of either PAD2 or citrulline residues could not be evaluated in the RPE layer due to the high autofluorescence levels in this layer. Interestingly, higher deimination immunoreactivity was detected in AMD retinal lysates. However, no significant changes in PAD2 were detected in the AMD and non-AMD retinas and RPE lysates. Our observations show increased levels of protein deimination but not PAD2 in AMD retinas and RPE, suggesting a reduced rate of turnover of deiminated proteins in these AMD retinas.

Indexed as

AdultAgedAged, 80 and overCitrullineEye BanksFemaleHumansHydrolasesImmunohistochemistryMacular DegenerationMaleMiddle AgedProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 2Protein Processing, Post-TranslationalRetinaCitrullineHydrolasesPADI2 protein, humanProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 2

Identifiers

PMID23562679
PMCPMC3683981
OpenAlexW2004035916

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.